Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Incomplete intestinal obstruction]

T Ozawa1, T Ueda, M Wakabayashi

  • 1Department of Surgery, Sakura Hospital, Toho University School of Medicine.

Ryoikibetsu Shokogun Shirizu
|January 1, 1994
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A phase II study of pembrolizumab plus chemotherapy with short-course radiotherapy as induction treatment for unresectable locally advanced esophageal squamous cell carcinoma: PALADIN trial.

ESMO gastrointestinal oncology·2026
Same author

Effect of prior anti-EGFR therapy and baseline ctDNA profiling on the efficacy of pertuzumab plus trastuzumab in HER2-amplified metastatic colorectal cancer: an integrated analysis of TRIUMPH/MyPathway.

ESMO open·2026
Same author

Short- and mid-term outcomes of transanal/transperineal minimally invasive surgery for locally recurrent rectal cancer.

Techniques in coloproctology·2026
Same author

Association of PD-L1 and PD-L2 expression and tumor-infiltrating lymphocytes in <i>BRAF</i> V600E-mutated metastatic colorectal cancer: GI-SCREEN <i>post-hoc</i> analysis.

ESMO gastrointestinal oncology·2026
Same author

ARCAD-Asia initiative: leveraging yesterday's data for tomorrow.

ESMO gastrointestinal oncology·2026
Same author

An open-label phase Ib/II study of trastuzumab deruxtecan combined with nivolumab and CAPOX for HER2-low gastroesophageal adenocarcinoma.

ESMO gastrointestinal oncology·2026
Same journal

[Substance-related mental disorders and expert testimony].

Ryoikibetsu shokogun shirizu·2003
Same journal

[Nicotine-related mental disorders].

Ryoikibetsu shokogun shirizu·2003
Same journal

[Organic solvent-related mental disorders].

Ryoikibetsu shokogun shirizu·2003
Same journal

[Hallucinogen related mental disorder].

Ryoikibetsu shokogun shirizu·2003
Same journal

[Methylphenidate-induced psychiatric disorders].

Ryoikibetsu shokogun shirizu·2003
Same journal

[Sensitization phenomenon].

Ryoikibetsu shokogun shirizu·2003
See all related articles